24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injury

Brain Research

Volumn 1319, Issue , 2010, Pages 1-12

  Cartagena, Casandra M ^a   Burns, Mark P ^a   Rebeck, G William ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

24S hydroxycholesterol; Cyp46; Lipid metabolism; Traumatic brain injury

Indexed keywords

24S HYDROXYCHOLESTEROL; ACETYL COENZYME A CARBOXYLASE; CHOLESTEROL 24S HYDROXYLASE; CHOLESTEROL DERIVATIVE; FATTY ACID SYNTHASE; GERANYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MESSENGER RNA; OXYGENASE; SQUALENE SYNTHASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID METABOLISM; MALE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; REGULATOR GENE; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CELL LINE; CELL LINE, TUMOR; CHOLESTEROL; GENE EXPRESSION REGULATION; HUMANS; HYDROXYCHOLESTEROLS; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; ORPHAN NUCLEAR RECEPTORS; STEROID HYDROXYLASES; TRANSCRIPTION, GENETIC;

EID: 76749094012     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.12.080     Document Type: Article

References (78)

1. Abildayeva K., Jansen P.J., Hirsch-Reinshagen V., Bloks V.W., Bakker A.H., Ramaekers F.C., de Vente J., Groen A.K., Wellington C.L., Kuipers F., and Mulder M. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem. 281 (2006) 12799-12808
2. Adams C.M., Reitz J., De Brabander J.K., Feramisco J.D., Li L., Brown M.S., and Goldstein J.L. Cholesterol and 25-hydroxycholesterol inhibit activation of SREBPs by different mechanisms, both involving SCAP and Insigs. J. Biol. Chem. 279 (2004) 52772-52780
3. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 260 (2006) 493-508
4. Bogdanovic N., Bretillon L., Lund E.G., Diczfalusy U., Lannfelt L., Winblad B., Russell D.W., and Bjorkhem I. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 314 (2001) 45-48
5. Brown M.S., and Goldstein J.L. SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 (1997) 331-340
6. Brown III J., Theisler C., Silberman S., Magnuson D., Gootardi-Littell N., Lee J.M., Yager D., Crowley J., Sambamuri K., Rahman M.M., Reiss A.B., Eckman C.B., and Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 279 (2004) 34674-34681
7. Brun T., Assimacopoulos-Jeannet F., Corkey B.E., and Prentki M. Long-chain fatty acids inhibit acetyl-CoA carboxylase gene expression in the pancreatic beta-cell line INS-1. Diabetes 46 (1997) 393-400
8. Cagen L.M., Deng X., Wilcox H.G., Park E.A., Raghow R., and Elam M.B. Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem. J. 385 (2005) 207-216
9. Cartagena C.M., Ahmed F., Burns M.P., Pajoohesh-Ganji A., Pak D.T., Faden A.I., and Rebeck G.W. Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain. J. Neurotrauma 25 (2008) 1087-1098
10. Costet P., Luo Y., Wang N., and Tall A.R. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275 (2000) 28240-28245
11. Dhillon H.S., Donaldson D., Dempsey R.J., and Prasad M.R. Regional levels of free fatty acids and Evans blue extravasation after experimental brain injury. J. Neurotrauma 11 (1994) 405-415
12. Dhillon H.S., Carman H.M., Zhang D., Scheff S.W., and Prasad M.R. Severity of experimental brain injury on lactate and free fatty acid accumulation and Evans blue extravasation in the rat cortex and hippocampus. J. Neurotrauma 16 (1999) 455-469
13. Dietschy J.M., and Turley S.D. Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45 (2004) 1375-1397
14. Du X., Pham Y.H., and Brown A.J. Effects of 25-hydroxycholesterol on cholesterol esterification and sterol regulatory element-binding protein processing are dissociable: implications for cholesterol movement to the regulatory pool in the endoplasmic reticulum. J. Biol. Chem. 279 (2004) 47010-47016
15. Ehehalt R., Keller P., Haass C., Thiele C., and Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 160 (2003) 113-123
16. Fagan A.M., Murphy B.A., Patel S.N., Kilbridge J.F., Mobley W.C., Bu G., and Holtzman D.M. Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp. Neurol. 151 (1998) 314-325
17. Fox G.B., Fan L., Levasseur R.A., and Faden A.I. Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse. J. Neurotrauma 15 (1998) 599-614
18. Fu X., Menke J.G., Chen Y., Zhou G., MacNaul K.L., Wright S.D., Sparrow C.P., and Lund E.G. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem. 276 (2001) 38378-38387
19. Fujiyoshi M., Ohtsuki S., Hori S., Tachikawa M., and Terasaki T. 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression. J. Neurochem. 100 (2007) 968-978
20. Fukumoto H., Deng A., Irizarry M.C., Fitzgerald M.L., and Rebeck G.W. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels. J. Biol. Chem. 277 (2002) 48508-48513
21. Gasparovic C., Rosenberg G.A., Wallace J.A., Estrada E.Y., Roberts K., Pastuszyn A., Ahmed W., and Graham G.D. Magnetic resonance lipid signals in rat brain after experimental stroke correlate with neutral lipid accumulation. Neurosci. Lett. 301 (2001) 87-90
22. Gilardi F., Viviani B., Galmozzi A., Boraso M., Bartesaghi S., Torri A., Caruso D., Crestani M., Marinovich M., and de Fabiani E. Expression of sterol 27-hydroxylase in glial cells and its regulation by liver X receptor signaling. Neuroscience 164 (2009) 530-540
23. Gill S., Chow R., and Brown A.J. Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised. Prog. Lipid Res. 47 (2008) 391-404
24. Gimpl G., Burger K., and Fahrenholz F. A closer look at the cholesterol sensor. Trends Biochem. Sci. 27 (2002) 596-599
25. He X., Jenner A.M., Ong W.Y., Farooqui A.A., and Patel S.C. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J. Neuropathol. Exp. Neurol. 65 (2006) 652-663
26. Hirsch-Reinshagen V., Maia L.F., Burgess B.L., Blain J.F., Naus K.E., McIsaac S.A., Parkinson P.F., Chan J.Y., Tansley G.H., Hayden M.R., Poirier J., Van Nostrand W., and Wellington C.L. The absence of ABCA1 decreases soluble ApoE levels but does not diminish amyloid deposition in two murine models of Alzheimer disease. J. Biol. Chem. 280 (2005) 43243-43256
27. Horton J.D., and Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr. Opin. Lipidol. 10 (1999) 143-150
28. Horton J.D., Shimomura I., Brown M.S., Hammer R.E., Goldstein J.L., and Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 101 (1998) 2331-2339
29. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
30. Huang Z.H., Lin C.Y., Oram J.F., and Mazzone T. Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 2019-2025
31. Hudry E., Van Dam D., Kulik W., De Deyn P.P., Stet F.S., Ahouansou O., Benraiss A., Delacourte A., Bougneres P., Aubourg P., and Cartier N. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol. Ther. 18 (2009) 44-53
32. Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., and Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 266-271
33. Johanson C.E., Duncan III J.A., Klinge P.M., Brinker T., Stopa E.G., and Silverberg G.D. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease. Cerebrospinal. Fluid Res. 5 (2008) 10
34. Jurevics H., and Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem. 64 (1995) 895-901
35. Kamada H., Sato K., Iwai M., Zhang W.R., Nagano I., Manabe Y., Shoji M., and Abe K. Temporal and spatial changes of free cholesterol and neutral lipids in rat brain after transient middle cerebral artery occlusion. Neurosci. Res. 45 (2003) 91-100
36. Karu K., Hornshaw M., Woffendin G., Bodin K., Hamberg M., Alvelius G., Sjovall J., Turton J., Wang Y., and Griffiths W.J. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. J. Lipid Res. 48 (2007) 976-987
37. Laffitte B.A., Repa J.J., Joseph S.B., Wilpitz D.C., Kast H.R., Mangelsdorf D.J., and Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. 98 (2001) 507-512
38. Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., and Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272 (1997) 3137-3140
39. Levin-Allerhand J.A., Lominska C.E., and Smith J.D. Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet. J. Nutr. Health Aging 6 (2002) 315-319
40. Liang Y., Lin S., Beyer T.P., Zhang Y., Wu X., Bales K.R., DeMattos R.B., May P.C., Li S.D., Jiang X.C., Eacho P.I., Cao G., and Paul S.M. A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes. J. Neurochem. 88 (2004) 623-634
41. Lund E., Bjorkhem I., Furster C., and Wikvall K. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim. Biophys. Acta 1166 (1993) 177-182
42. Lund E.G., Guileyardo J.M., and Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 7238-7243
43. Lund E.G., Xie C., Kotti T., Turley S.D., Dietschy J.M., and Russell D.W. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278 (2003) 22980-22988
44. Mak P.A., Laffitte B.A., Desrumaux C., Joseph S.B., Curtiss L.K., Mangelsdorf D.J., Tontonoz P., and Edwards P.A. Regulated expression of the apolipoprotein E/C-I/C-IV/C-II gene cluster in murine and human macrophages. A critical role for nuclear liver X receptors alpha and beta. J. Biol. Chem. 277 (2002) 31900-31908
45. Meir K., Kitsberg D., Alkalay I., Szafer F., Rosen H., Shpitzen S., Avi L.B., Staels B., Fievet C., Meiner V., Bjorkhem I., and Leitersdorf E. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J. Biol. Chem. 277 (2002) 34036-34041
46. Natali F., Siculella L., Salvati S., and Gnoni G.V. Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells. J. Lipid Res. 48 (2007) 1966-1975
47. Nikawa J., Tanabe T., Ogiwara H., Shiba T., and Numa S. Inhibitory effects of long-chain acyl coenzyme A analogues on rat liver acetyl coenzyme A carboxylase. FEBS Lett. 102 (1979) 223-226
48. Ohyama Y., Meaney S., Heverin M., Ekstrom L., Brafman A., Shafir M., Andersson U., Olin M., Eggertsen G., Diczfalusy U., Feinstein E., and Bjorkhem I. Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes. J. Biol. Chem. 281 (2006) 3810-3820
49. Olkkonen V.M., and Hynynen R. Interactions of oxysterols with membranes and proteins. Mol. Aspects Med. 30 (2009) 123-133
50. Papassotiropoulos A., Lutjohann D., Bagli M., Locatelli S., Jessen F., Buschfort R., Ptok U., Bjorkhem I., von Bergmann K., and Heun R. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J. Psychiatr. Res. 36 (2002) 27-32
51. Pilitsis J.G., Coplin W.M., O'Regan M.H., Wellwood J.M., Diaz F.G., Fairfax M.R., Michael D.B., and Phillis J.W. Free fatty acids in cerebrospinal fluids from patients with traumatic brain injury. Neurosci. Lett. 349 (2003) 136-138
52. Pitas R.E., Boyles J.K., Lee S.H., Hui D., and Weisgraber K.H. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J. Biol. Chem. 262 (1987) 14352-14360
53. Poirier J., Baccichet A., Dea D., and Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55 (1993) 81-90
54. Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., and Goldstein J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6511-6518
55. Raghow R., Yellaturu C., Deng X., Park E.A., and Elam M.B. SREBPs: the crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol. Metab. 19 (2008) 65-73
56. Ramirez D.M., Andersson S., and Russell D.W. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J. Comp. Neurol. 507 (2008) 1676-1693
57. Rebeck G.W. Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis. J. Mol. Neurosci. 23 (2004) 219-224
58. Repa J.J., Liang G., Ou J., Bashmakov Y., Lobaccaro J.M., Shimomura I., Shan B., Brown M.S., Goldstein J.L., and Mangelsdorf D.J. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14 (2000) 2819-2830
59. Repa J.J., Lund E.G., Horton J.D., Leitersdorf E., Russell D.W., Dietschy J.M., and Turley S.D. Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. J. Biol. Chem. 275 (2000) 39685-39692
60. Repa J.J., Turley S.D., Lobaccaro J.A., Medina J., Li L., Lustig K., Shan B., Heyman R.A., Dietschy J.M., and Mangelsdorf D.J. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289 (2000) 1524-1529
61. Rubink D.S., and Winder W.W. Effect of phosphorylation by AMP-activated protein kinase on palmitoyl-CoA inhibition of skeletal muscle acetyl-CoA carboxylase. J. Appl. Physiol. 98 (2005) 1221-1227
62. Sabol S.L., Brewer Jr. H.B., and Santamarina-Fojo S. The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J. Lipid Res. 46 (2005) 2151-2167
63. Sato R., Inoue J., Kawabe Y., Kodama T., Takano T., and Maeda M. Sterol-dependent transcriptional regulation of sterol regulatory element-binding protein-2. J. Biol. Chem. 271 (1996) 26461-26464
64. Saucier S.E., Kandutsch A.A., Gayen A.K., Swahn D.K., and Spencer T.A. Oxysterol regulators of 3-hydroxy-3-methylglutaryl-CoA reductase in liver. J. Biol. Chem. 264 (1989) 6863-6869
65. Shafaati M., Solomon A., Kivipelto M., Bjorkhem I., and Leoni V. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders. Neurosci. Lett. 425 (2007) 78-82
66. Shaw G., Morse S., Ararat M., and Graham F.L. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16 (2002) 869-871
67. Shimomura I., Shimano H., Horton J.D., Goldstein J.L., and Brown M.S. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 99 (1997) 838-845
68. Sun L.P., Seemann J., Goldstein J.L., and Brown M.S. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6519-6526
69. Tall A.R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J. Intern. Med. 263 (2008) 256-273
70. Teunissen C.E., Floris S., Sonke M., Dijkstra C.D., De Vries H.E., and Lutjohann D. 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J. Neurosci. Res. 85 (2007) 1499-1505
71. Thewke D.P., Panini S.R., and Sinensky M. Oleate potentiates oxysterol inhibition of transcription from sterol regulatory element-1-regulated promoters and maturation of sterol regulatory element-binding proteins. J. Biol. Chem. 273 (1998) 21402-21407
72. Turley S.D., Burns D.K., Rosenfeld C.R., and Dietschy J.M. Brain does not utilize low density lipoprotein-cholesterol during fetal and neonatal development in the sheep. J. Lipid Res. 37 (1996) 1953-1961
73. Turley S.D., Burns D.K., and Dietschy J.M. Preferential utilization of newly synthesized cholesterol for brain growth in neonatal lambs. Am. J. Physiol. 274 (1998) E1099-1105
74. Vaya J., and Schipper H.M. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J. Neurochem. 102 (2007) 1727-1737
75. Wang Y., Muneton S., Sjovall J., Jovanovic J.N., and Griffiths W.J. The effect of 24S-hydroxycholesterol on cholesterol homeostasis in neurons: quantitative changes to the cortical neuron proteome. J. Proteome Res. 7 (2008) 1606-1614
76. Whitney K.D., Watson M.A., Collins J.L., Benson W.G., Stone T.M., Numerick M.J., Tippin T.K., Wilson J.G., Winegar D.A., and Kliewer S.A. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16 (2002) 1378-1385
77. Worgall T.S., Sturley S.L., Seo T., Osborne T.F., and Deckelbaum R.J. Polyunsaturated fatty acids decrease expression of promoters with sterol regulatory elements by decreasing levels of mature sterol regulatory element-binding protein. J. Biol. Chem. 273 (1998) 25537-25540
78. Xie C., Lund E.G., Turley S.D., Russell D.W., and Dietschy J.M. Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res. 44 (2003) 1780-1789